INTRODUCTION
============

It is increasingly clear that the gut microbiota is essential for maintaining health. Until recently its role in human health had remained largely unknown, mainly due to the lack of methods to study unculturable microorganisms, which constitute a large fraction of the gut microbiota. However, in recent years the development of next generation sequencing (NGS) methods has facilitated the performance of metagenomic studies to determine gut microbiome composition. These methods, together with the use of gnotobiotic animals have demonstrated the importance of the microbiota for host health, providing the basis for the use of dietary interventions aimed at counteracting microbiota aberrancies.

Next generation sequencing have indicated that, in spite of a high inter-individual variability, human intestinal bacterial populations of adults can be classified into three robust clusters called "enterotypes," dominated by *Bacteroides*, *Prevotella*, and *Ruminococcus* ([@B9]). These enterotypes seem independent of nationality, age, gender, and body mass index but are influenced by long-term dietary habits ([@B92]). In addition, some microbiota alterations are associated with different human diseases ([@B82]; [@B71]; [@B53]). However, to date most of the larger studies have focused on adult populations and we are still far from clearly understanding as to how the microbiota affects health at different life stages. Interestingly, whilst the microbiota shows a high stability and resilience to change during adult life, it seems to be far more unstable at early infancy and senescence.

The initial steps of microbiota establishment in the newborn are critical for a proper development ([@B32]; [@B20]), and may be affected by several factors ([@B51]). During the initial colonization the microbiota suffers microbial succession phenomena and is unstable ([@B93]). Similarly, at senescence the microbiota suffers new changes, becoming unstable again ([@B23], [@B24]; [@B76]). Therefore, it is at these extremes of life where strategies aiming at microbiome modulation may have a deeper impact on health.

CULTURE INDEPENDENT AND OMIC TECHNIQUES FOR THE STUDY OF THE INTESTINAL MICROBIOTA
==================================================================================

Most studies on the intestinal microbiota have focused on microbial communities and their variation among human subgroups, in order to define which microorganisms are in the gut and how their presence/absence correlates with human health. Compositional variation can be detected through polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE) of 16S rRNA gene, coupled to Sanger sequencing ([@B47]). Fluorescence *in situ* hybridization (FISH) and quantitative PCR (qPCR) also allow quantification of selected bacteria in mixed populations, but requires design of probes/primers and therefore cannot detect unknown or low abundance microbial groups. Therefore, total 16S rRNA gene sequencing through NGS platforms (454-Pyrosequencing, MiSeq, Ion Torrent, or SOLID) is becoming the gold-standard for overcoming the limitations of the aforementioned methods. NGS platforms are improving to offer cheaper alternatives and better resolution to detect unculturable, unknown and low frequent bacteria ([@B23]; [@B39]; [@B63]). Significant bioinformatic efforts are required to analyze the millions of reads generated through NGS. Alternative high-throughput methods include oligonucleotide microarrays (PhyloChip, Microbiota Array, HuGChip, and HITChip), that determine the presence and abundance of thousands of phylotypes in a sample ([@B66]; [@B81]) although *de novo* probe design, optimization and validation is time consuming ([@B86]). Microarray and NGS showed good correlation though minor differences may appear depending, among other factors, on the origin of samples and number of 16S rRNA gene copies. Both techniques can be complementary: microarray technology is a powerful method for routine study of many samples whereas NGS enables a detailed understanding of microbial gene diversity ([@B75]).

Current efforts focus on shotgun metagenomic sequencing to generate comprehensive gene catalogs reflecting what metabolic functionalities the intestinal microbiota encodes ([@B71]; [@B25]; [@B72]). Despite the large compositional variation among healthy individuals, distribution of functionality is more conserved, suggesting that microbiota metabolic potential might be more relevant than its taxonomical composition. Metagenomics also revealed activities exclusive from gut environments and provided the basis to describe new vitamins synthesis and signaling pathways ([@B52]). Moreover, shotgun sequencing coupled with *in vitro* enrichment cultures from fecal samples, allowed complete genomes assembly of unculturable methanogenic archaeons, demonstrating that low frequency bacteria encode functionalities that might be relevant in the cross-talk between microbiota and host ([@B21]; [@B59]). Functional microarrays are also available such as the CAZymes Chip that detects thousands of carbohydrate degrading activities encoded by a microbiota sample ([@B33]).

What gut microbes are actually doing can be investigated through a combination of metatranscriptomics, metaproteomics, and metabolomics approaches to analyze RNA, protein and small metabolite pools from feces ([@B44]; [@B61]; [@B40]; [@B83]), which are subsequently identified by comparison against appropriate databases. Comprehension of the role that human microbiota plays in health and disease requires integration of taxonomical and metabolic features as well as the understanding of the cross-talk between microbiota and host. Metabolomics provide the basis to evaluate dietary intervention's effects on gut microbiota composition/functionality and host metabolic outcomes ([@B61]; [@B26]). Development of computational tools to integrate results from multiple levels still remains a challenge.

INTESTINAL MICROBIOTA, IMMUNE SYSTEM, AND NUTRITIONAL STATUS THROUGHOUT LIFE
============================================================================

NEWBORNS
--------

Traditionally, it was thought that microbial colonization of the gastrointestinal tract begins immediately after birth. Recent studies have shown the presence of microorganisms in placenta, amniotic fluid, umbilical cord blood, and meconium ([@B50]; [@B27]; [@B64]; [@B1]). The classical pattern of early microbial development involves a first colonization by facultative anaerobes, which deplete the initial oxygen supplies creating a more suitable environment for the subsequent colonization by strict anaerobes ([@B37]). From an initial low diversity and complexity the intestinal microbiota reaches a stable population similar to that of an adult around 2--3 years of age ([@B56]; [@B93]). The microbial population established in the initial stages of life has a profound impact on epigenetic programming and future homeostasis and well-being of the individual ([@B67]; [@B22]). In this way, it is known that maternal and neonatal under-nutrition may promote an inadequate gut microbiota composition and functionality, accounting for deviant programming of later immunity and of regulation of genes involved in lipid and carbohydrate metabolism ([@B22]; [@B55]).

Several factors influence the establishment and composition of the infant intestinal microbiota: feeding type, delivery mode, gestational age or the use of antibiotics, among others ([@B68]). Breast milk is considered the optimal feeding pattern for newborns and the WHO recommends exclusive breast-feeding up to 6 months of age and then supplemental breast-feeding up to 2 years of age ([@B89]). Short- and long-term health benefits associated with breast-feeding have been reported and breast-fed infants are considered healthier, showing lower incidence of enteric and non-enteric infections, necrotizing enterocolitis (NEC), allergy and atopic disorders or diabetes compared with formula-fed infants ([@B57]). Breast milk contains a wide range of protective compounds including carbohydrates (such as oligosaccharides with strong prebiotic activity and ability to displace pathogens), nucleotides, immunoglobulins, cytokines, short chain fatty acids (SCFA), and lactoferrin, and is a source of beneficial bacteria ([@B62]; [@B78]; [@B19]). The intestine of breast-fed infants was traditionally considered to be dominated by bifidobacteria but recent studies using high-throughput 16S rDNA techniques demonstrated that Proteobacteria dominate the infant intestinal microbiota ([@B4]; [@B36]). However, breast-fed infants presented higher levels and abundance of bifidobacteria and lower levels of potential pathogens than formula-fed babies, in which a more diverse microbiota dominated by *Bacteroides* and Clostridia resides, with higher levels of *Klebsiella* ([@B35]; [@B15]). Differential patterns of SCFA production have been found in breast-fed vs. formula-fed infants ([@B57]; [@B5]). Weaning promoted higher levels of Bacteroidetes and Firmicutes as well as functional genes characteristic of adult microbiome whereas it decreases Bifidobacteria and Proteobacteria ([@B34]; [@B56]). The establishment of the so-called human "enterotypes" seems to start around 18 months, although at this early age these enterotypes are still susceptible to shifting ([@B14]).

ADULTS
------

The human gut microbiota reaches its maximum complexity at adolescence following a gradual increase in the phylogenetic diversity of the microbiome during adulthood. The gut of healthy adults is populated by around 10^14^ bacteria which outnumber the total eukaryotic cells of the human body. This ecosystem is dominated by the phyla Bacteroidetes and Firmicutes while Actinobacteria, Proteobacteria, and Verrucomicrobia are represented in lower percentages ([@B9]). In addition to bacterial and eukaryotic cells, the main representative of *Archaea* in the adult gut is the methanogenic species *Methanobrevibacter smithii* ([@B30]).

The human microbiome contributes to shaping the immune system and should not be underestimated as a key factor in the maintenance of human health, being a key player in vitamin production, digestion, energy homeostasis, angiogenesis and maintenance of intestinal barrier integrity. The human gut microbiota appears altered in several disease states including obesity, inflammatory bowel disease and irritable bowel syndrome. The responses of the microbiota to antibiotic treatment can vary depending on individuals and is influenced by the prior exposure and the type of antibiotic used ([@B79]).

The "adult-like" gut microbiota ecosystem maintains a high stability and homeostasis in the absence of significant ecological stressors but intestinal dysbiosis appears with the old age.

ELDERLY
-------

Aging has been defined as "the regression of physiological function accompanied by advancement of age" ([@B91]) and is associated with physiological changes in the gastrointestinal tract, as well as changes in dietary patterns and immune function. Aging is intimately linked with a decline in the normal function of the immune system ([@B46]) which results in an increased vulnerability of individuals against common infections (immunosenescence). Although physiological phenomena linked to aging vary among people and is influenced by external factors, according to the WHO most westernized countries have accepted the chronological age of 65 years as a definition of "elderly." Malnutrition is a classical feature of old age and is linked to physiological changes that impact food digestion and absorption. Increased threshold for taste and smell, swallowing difficulties and masticatory dysfunction in the elderly can result in nutritionally imbalanced diets. Elderly people also suffer from atrophic gastritis with a decreased absorption of calcium, ferric iron, and vitamin B12 ([@B16]). In addition, reduced intestinal motility leads to fecal impaction and constipation and an increased intestinal transit time is linked with reduced bacterial excretion and augmentation of bacterial protein fermentation, which consequently alters the gut fermentative process ([@B16]).

The imbalance between pro-inflammatory and anti-inflammatory status in aged people results in a low-grade chronic systemic inflammation known as "inflammaging." Inflammaging contributes to frailty, which is considered a hallmark of unhealthy aging, and degenerative disorders ([@B16]). The main changes in the immune system include reduced humoral responses, decreases in dendritic cells efficiency to activate T and B cell populations, declination in the generation of new naive T and B cells, and reduced natural killer cell activity ([@B84]). Also augmented levels of pro-inflammatory cytokines such as TNF-α, IL12 and the chemokine IL8, and a reduction in NK cells cytotoxic activity have been reported ([@B76]). These alterations contribute to the prevalence of cancer, autoimmune and chronic diseases such as Alzheimer's disease, atherosclerosis, osteoarthritis and insulin resistance ([@B46]). The origins and drivers of the age-related chronic inflammation are not entirely clear but there is a growing body of evidence suggesting the role of the age-related intestinal microbiota in inflammaging.

The core microbiota composition of elderly individuals significantly differs from healthy adults and the set of microbial genes required for the proper maintenance of the gut homeostasis is likely to be different than that required for younger populations ([@B71]). The abundance of the members of the dominant phyla of the gut microbiota, Firmicutes and Bacteroidetes in elders is controversial and seems to be country dependent ([@B16]). A higher proportion of Bacteroidetes and a reduced stability of the microbial community has been reported in the elderly Irish population, whereas the proportion of Bacteroidetes remains constant in Italian elderly ([@B17]). The age-related intestinal microbiota changes include a reduction in species diversity of most bacterial groups which makes microbiota less resistant to major fluctuations in response to several environmental factors. Shifts in the dominant species within several bacterial groups, decline in beneficial microorganisms, increase of facultative anaerobic bacteria and decrease in the availability of total SCFA have also been described ([@B76]). These modifications of the intestinal microbiota may contribute to the establishment of a state prone to disease and might increase the susceptibility to infections, such as those caused by *Clostridium difficile* ([@B16]).

NUTRITIONAL STRATEGIES FOR RESTORING A BALANCED MICROBIOTA AT EXTREME AGES OF LIFE
==================================================================================

The microbiota of specific healthy human groups is considered a reference to identify targets for intervention in order to promote a balanced microbiota in populations at extreme ages of life. The gold standard microbiota in infants is that of full-term vaginally delivered breast-fed babies. Early stages of intestinal colonization when the microbiota is still developing, is the key period to apply modulation strategies. Identified alterations of the infant microbiota generally impact on microbial diversity, anaerobe/facultative anaerobes ratio, incidence and levels of *Enterobacteriaceae* and intestinal pathogens, SCFA production pattern, and functionality of metagenomes ([@B4],[@B5],[@B7]). Lowering the incidence and severity of NEC as well as the infection risk in premature infants is a target of relevance ([@B88]). The main targets for nutritional intervention in order to restore a balanced microbiota in newborns are summarized in **Table [1](#T1){ref-type="table"}**.

###### 

Main targets for nutritional intervention in order to restore a balanced microbiota at extreme ages of life.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Human groups                          Intestinal microbiota alterations identified                                                                                      Impact on extra-intestinal locations                           Experimental techniques for studying the intestinal microbiota   Reference
  ------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------
  ***Newborns***                                                                                                                                                                                                                                                                                          

  **Formula-fed**                       ✓ Dominated by *Bacteroides* and Clostridia\                                                                                      ✓ Risk of obesity in childhood and adulthood\                  FISH\                                                            [@B35], [@B15], [@B10], [@B20], [@B48], [@B90]
                                        ✓ Increased *Atopobium* levels\                                                                                                   ✓ Induction of Th1 cytokines in children\                      16S rRNA gene sequencing\                                        
                                        ✓ Higher levels of potential pathogens, such as *Clostridium difficile*\                                                          ✓ Worse neurodevelopmental outcome than breast-fed infants     GC                                                               
                                        ✓ Elevated propionate levels\                                                                                                                                                                                                                                     
                                        ✓ Higher diversity                                                                                                                                                                                                                                                

  **Premature**\                        ✓ Lower levels of *Bifidobacterium* and *Bacteroides*\                                                                            ✓ Immature system immune\                                      qPCR\                                                            [@B12], [@B49], [@B5], [@B11]
                                        ✓ Elevated levels of potential pathogens, such as *Klebsiella pneumoniae*\                                                        ✓ Lower cognitive capacities\                                  PCR-DGGE/TGGE\                                                   
                                        ✓ Elevated facultative anaerobe to strict anaerobes ratio\                                                                        ✓ Risk of infections, NEC and death\                           16S rRNA gene sequencing\                                        
                                        ✓ Reduced levels of SCFA\                                                                                                                                                                        GC                                                               
                                        ✓ Lower diversity                                                                                                                                                                                                                                                 

  **C-section delivery**                ✓ Dominated by skin microorganisms: *Staphylococcus*, *Corynebacterium*, Propionibacterium\                                       ✓ Risk of asthma, allergies or atopic diseases in adulthood\   qPCR\                                                            [@B77], [@B18], [@B28], [@B42], [@B10], [@B20]
                                        ✓ Elevated levels of *Escherichia, Shigella, Bacteroides*\                                                                        ✓ Risk of obesity in adulthood\                                PCR-DGGE/TGGE\                                                   
                                        ✓ Reduced levels of *Bifidobacterium*\                                                                                            ✓ Risk of diabetes I                                           16S rRNA gene sequencing\                                        
                                        ✓ Lower diversity                                                                                                                                                                                                                                                 

  **Antibiotic treatment**              ✓ Elevated levels of enterobacteria and enterococci\                                                                              ✓ Risk of asthma, allergies in adulthood\                      qPCR\                                                            [@B80], [@B35], [@B39]
                                        ✓ Lower levels of *Bifidobacterium*\                                                                                              ✓ Risk of obesity in adulthood                                 FISH\                                                            
                                        ✓ Lower diversity                                                                                                                                                                                16S rRNA gene sequencing                                         

  ***Elderly***                                                                                                                                                                                                                                                                                           

  **Healthy elderly**                   ✓ Country dependent changes in Firmicutes/Bacteroidetes ratio\                                                                    ✓ Decline in the normal function of the immune system\         qPCR\                                                            [@B23], [@B17], [@B76], [@B46]
                                        ✓ Elevated facultative anaerobes\                                                                                                 ✓ Risk of autoimmune and chronic diseases\                     16S rRNA gene sequencing\                                        
                                        ✓ Reduced level SCFA\                                                                                                             ✓ Poor response to vaccination\                                GC\                                                              
                                        ✓ Lower diversity                                                                                                                 ✓ Increased vulnerability to infection                                                                                          

  **Elderly under medical treatment**   ✓ Lower levels Bacteroidetes, *Bifidobacterium, Clostridium* cluster XIVa, *Faecalibacterium prausnitzii* members (Cluster IV)\   ✓ Increased susceptibility to infections by *C. difficile*     Culture-based techniques\                                        [@B65], [@B17], [@B54]
                                        ✓ Increased levels of *Lactobacillus* after antibiotic therapy\                                                                                                                                  qPCR\                                                            
                                        ✓ Lower diversity                                                                                                                                                                                16S rRNA gene sequencing\                                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In the elderly, the microbiota of a younger population of healthy adults otherwise sharing similar characteristics in terms of geographic location and diet as the older people is considered the benchmark of healthy microbiota. This reference group must have had a past socio-economic status as similar as possible to the elders: a history of exposure to different environments in the two populations may lead to attribute to aging, variations due to the action of different environmental factors such as those linked to social habits, nutritional patterns, or residence location ([@B24]; [@B76]). Loss of the community-associated microbiota, that is the set of microorganisms shared by individuals from a given social group, correlated with increased frailty. The reduced levels of *C. leptum* and *Blautia coccoides* and the higher incidence of *C. difficile* infections are relevant targets ([@B76]; [@B70]). Some nutritional deficiencies of elders are related with lower intakes of specific nutrients which are important for maintaining the immune and gastrointestinal functions and which are a consequence of the general loss of functionality of the gastrointestinal tract ([@B43]; [@B70]). Therefore, nutritional strategies in elders should consider the intestinal microbiota, immune system, and nutritional deficiencies (**Table [1](#T1){ref-type="table"}**).

Different approaches have been proposed for restoring a balanced microbiota. Fecal transplantation is known from many years ago ([@B31]); although a renewed interest has arisen in recent time, this alternative has currently important ethical concerns and legal barriers ([@B73]); however, it could be considered as proof of principle research that would help to find a definite cocktail of strains to be administered as a corrective measure of intestinal dysbiosis ([@B69]).

Probiotics are "live microorganisms which when administered in adequate amount confer a health benefit on the host" ([@B38]). The most used probiotics in foods are lactobacilli and bifidobacteria. Probiotics may interact with the intestinal microbiota, inhibit enteric pathogens and modulate the immune system. Prebiotics are "selectively fermented ingredients that result in specific changes in the composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon host health" ([@B74]). Prebiotics usually are complex carbohydrates naturally present in vegetables and other foods or can be industrially produced as ingredients. Their beneficial effects are linked to promotion of changes on the composition and metabolic activity of the intestinal microbiota ([@B74]). The inclusion of probiotics and prebiotics in foods has been extensively used for modulating the gut microbiota. However, to date the specific needs of defined target populations, such as the extremes of life, in terms of microbiota modulation have not been taken into account for probiotic or prebiotic selection and products formulation. A schematic representation of the steps involved in designing nutritional intervention strategies for human extreme ages is provided in **Figure [1](#F1){ref-type="fig"}**.

![**Schematic representation of the steps involved in designing nutritional interventions to improve functionality of specific human population groups in the extreme ages of life: (newborns and elders).** Step 1: defining reference populations for comparative studies. Step 2: identifying intestinal and extraintestinal targets for intervention. Step 3: proving functional efficacy of different nutritional strategies.](fgene-05-00406-g001){#F1}

INTEGRATED PERSPECTIVE AND FUTURE TRENDS OF THE HUMAN INTESTINAL MICROBIOTA AND DIET
====================================================================================

The development of dietary intervention strategies specifically targeted to populations at the extreme ages of life, may constitute an interesting approach ([@B6]). A number of studies support the benefits of specific probiotics and prebiotics in adults ([@B70]), although the evidence is still scarce in infants and elders. Several studies indicate that prebiotics may be effective in decreasing the rate of overall infections in infants ([@B58]) and that maternal probiotic supplementation may decrease the incidence of NEC in breastfed preterm babies ([@B13]). However, there is still a need for long-term follow-up of initiated probiotic studies to assess the impact of early life interventions for late efficacy ([@B87]). Therefore, the selection of probiotics and prebiotics included in tailor-made foods for human populations at extreme ages of life and targeting well defined microbiota alterations, is a key future action ([@B3]; [@B2]; [@B29]). This is pointed out by recent reports underlining a high inter-individual variability in the response to probiotics ([@B85]; [@B45]) and important differences in the effect of the same probiotics and prebiotics on the intestinal microbiota from different human groups ([@B8]).

Moreover, considering the wide impact of the microbiota on host physiology it may be time for addressing new targets such as the age-related chronic-inflammation ([@B60]) or the maintenance or correct development of cognitive function in elders and preterm babies, respectively ([@B41]). In addition, these population groups may require specific and nutritionally adequate products able to satisfy their particular requirements. Such knowledge should now be integrated into the development of a new generation of highly adapted functional food products.
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